Your browser is no longer supported. Please, upgrade your browser.
LUMO [NASD]
Lumos Pharma, Inc.
Index- P/E- EPS (ttm)-3.22 Insider Own0.90% Shs Outstand8.36M Perf Week-4.22%
Market Cap66.31M Forward P/E- EPS next Y-3.86 Insider Trans425.17% Shs Float5.98M Perf Month-15.27%
Income-27.20M PEG- EPS next Q-1.05 Inst Own34.50% Short Float0.99% Perf Quarter-27.33%
Sales0.12M P/S539.07 EPS this Y91.00% Inst Trans-10.17% Short Ratio2.93 Perf Half Y-23.89%
Book/sh11.26 P/B0.68 EPS next Y-3.80% ROA-23.20% Target Price27.17 Perf Year-48.57%
Cash/sh11.71 P/C0.66 EPS next 5Y15.20% ROE-25.90% 52W Range7.23 - 36.72 Perf YTD-78.41%
Dividend- P/FCF- EPS past 5Y40.70% ROI-10.60% 52W High-79.00% Beta1.73
Dividend %- Quick Ratio17.50 Sales past 5Y-69.90% Gross Margin- 52W Low6.61% ATR0.46
Employees31 Current Ratio17.50 Sales Q/Q-69.70% Oper. Margin- RSI (14)30.66 Volatility4.36% 5.84%
OptionableNo Debt/Eq0.00 EPS Q/Q-530.80% Profit Margin- Rel Volume1.08 Prev Close7.50
ShortableYes LT Debt/Eq0.00 EarningsNov 03 AMC Payout- Avg Volume20.17K Price7.71
Recom1.80 SMA20-13.17% SMA50-16.70% SMA200-27.56% Volume21,734 Change2.82%
Mar-11-21Upgrade Stifel Hold → Buy $4 → $24
Dec-03-20Initiated Cantor Fitzgerald Buy $32
Aug-26-20Initiated Piper Sandler Overweight $26
Aug-17-20Resumed ROTH Capital Buy $51
Aug-04-20Initiated H.C. Wainwright Buy $33
Nov-24-21 10:00AM  
Nov-15-21 11:14AM  
Nov-10-21 05:06PM  
Nov-08-21 10:42AM  
Nov-03-21 04:01PM  
Oct-21-21 04:05PM  
Sep-02-21 08:00AM  
Aug-16-21 09:58AM  
Aug-05-21 08:00AM  
Aug-03-21 08:00AM  
Aug-02-21 08:00AM  
Jul-26-21 04:18PM  
Jul-22-21 08:00AM  
Jul-20-21 04:01PM  
Jun-28-21 08:00AM  
May-19-21 09:00AM  
May-13-21 09:00AM  
May-05-21 04:01PM  
02:30PM  
Apr-28-21 09:00AM  
Apr-27-21 08:00AM  
Apr-20-21 04:05PM  
Apr-14-21 04:05PM  
Mar-20-21 11:00AM  
Mar-11-21 04:05PM  
Mar-09-21 04:05PM  
01:30PM  
Mar-04-21 09:00AM  
Mar-02-21 04:05PM  
12:30PM  
Feb-22-21 04:15PM  
Feb-16-21 04:01PM  
Dec-18-20 09:00AM  
Dec-16-20 02:19AM  
Nov-30-20 05:35PM  
Nov-23-20 07:43PM  
Nov-10-20 04:01PM  
02:30PM  
Nov-03-20 12:30PM  
Oct-29-20 09:00AM  
Oct-27-20 04:01PM  
Aug-27-20 09:00AM  
Aug-13-20 04:01PM  
Jul-28-20 04:01PM  
Jul-27-20 04:05PM  
Jun-19-20 08:21AM  
Jun-10-20 03:41PM  
May-28-20 04:01PM  
May-27-20 04:27PM  
May-26-20 10:36AM  
Apr-24-20 08:00AM  
Apr-02-20 04:05PM  
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone stimulating small molecule, which is in Phase 2b clinical trial for the treatment of pediatric growth hormone deficiency. The company was founded in 2011 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LALANDE KEVIN M.DirectorSep 08Buy11.2110,000112,116730,446Sep 10 04:57 PM
McKew John C.Chief Scientific OfficerSep 08Sale11.302,21425,01831,012Sep 10 04:58 PM
LALANDE KEVIN M.DirectorSep 07Buy11.1110,000111,139720,446Sep 07 05:56 PM
LALANDE KEVIN M.DirectorSep 03Buy11.358,10091,905710,446Sep 07 05:56 PM
LALANDE KEVIN M.DirectorSep 02Buy11.236,30070,739702,346Sep 07 05:56 PM
LALANDE KEVIN M.DirectorSep 01Buy10.874,58949,892696,046Sep 01 06:46 PM
LALANDE KEVIN M.DirectorAug 31Buy10.706,00064,181691,457Sep 01 06:46 PM
LALANDE KEVIN M.DirectorAug 30Buy10.528,62590,738685,457Sep 01 06:46 PM
LALANDE KEVIN M.DirectorAug 27Buy10.504,98152,282677,832Aug 27 07:16 PM
LALANDE KEVIN M.DirectorAug 26Buy10.076,20062,430672,851Aug 27 07:16 PM
LALANDE KEVIN M.DirectorAug 25Buy9.8714,900147,078666,651Aug 27 07:16 PM
LALANDE KEVIN M.DirectorAug 24Buy9.4510,775101,871651,751Aug 24 06:19 PM
LALANDE KEVIN M.DirectorAug 23Buy9.5837,800362,150640,976Aug 24 06:19 PM
LALANDE KEVIN M.DirectorAug 20Buy8.7335,679311,638603,176Aug 24 06:19 PM
LALANDE KEVIN M.DirectorAug 19Buy8.4520,000168,970567,497Aug 19 08:14 PM
LALANDE KEVIN M.DirectorAug 18Buy8.7328,870252,009547,497Aug 19 08:14 PM
LALANDE KEVIN M.DirectorAug 17Buy8.4716,000135,446518,627Aug 19 08:14 PM
LALANDE KEVIN M.DirectorAug 16Buy7.9631,000246,717502,627Aug 16 06:09 PM
LALANDE KEVIN M.DirectorAug 13Buy7.8631,000243,744471,627Aug 16 06:09 PM
Schuchart AaronChief Business OfficerAug 12Buy7.421,70012,6143,037Aug 13 04:32 PM
LALANDE KEVIN M.DirectorAug 12Buy7.5531,000233,932440,627Aug 16 06:09 PM
McCracken Joseph SDirectorAug 11Buy7.557,47556,4068,551Aug 13 04:31 PM
Schuchart AaronChief Business OfficerAug 11Buy7.353002,2051,337Aug 13 04:32 PM
Flynn James E10% OwnerJan 08Sale22.31106,5122,376,099784,568Jan 08 05:54 PM
Flynn James E10% OwnerJan 07Sale24.5416,172396,821891,080Jan 08 05:54 PM
Flynn James E10% OwnerJan 06Sale22.4829,039652,703907,252Jan 08 05:54 PM